首页|期刊导航|江苏大学学报(医学版)|ATP6V1B2通过促进溶酶体酸化抑制脂毒损伤肝细胞脂质沉积

ATP6V1B2通过促进溶酶体酸化抑制脂毒损伤肝细胞脂质沉积OA

ATP6V1B2 inhibits lipid deposition in lipotoxin-exposed hepatocytes by promoting lysosomal acidification

中文摘要英文摘要

目的:探究ATP6V1B2促进肝细胞溶酶体酸化抑制脂质沉积的作用和机制.方法:高脂饮食喂养雄性C57BL/6小鼠14周构建肝脂肪变性模型,采用油酸和棕榈酸混合物诱导肝细胞株L02、HepG2发生脂毒性损伤,通过siRNA和质粒转染敲低或过表达L02细胞中ATP6V1B2基因.蛋白质免疫印迹法和qRT-PCR法分别检测ATP6V1B2的蛋白和mRNA表达;油红O染色和尼罗红染色检测肝细胞脂质沉积;溶酶体探针检测脂毒性肝细胞溶酶体活性;吖啶橙染色检测溶酶体膜完整性;利用JASPAR数据库预测调节ATP6V1B2的转录因子,验证转录因子调控ATP6V1B2表达的作用.结果:与正常对照组相比,高脂饮食小鼠肝组织和脂毒性肝细胞中ATP6V1B2表达均明显下降(P<0.05).敲低ATP6V1B2可加重肝细胞脂质沉积,抑制溶酶体酸化并增加溶酶体膜通透性.过表达ATP6V1B2能够缓解肝细胞脂质沉积.转录因子特异性蛋白1(SP1)可调节ATP6V1B2的表达,与对照组相比,沉默SP1可明显上调L02细胞ATP6V1B2的mRNA和蛋白表达(P<0.01).结论:ATP6V1B2可能通过促进肝细胞溶酶体酸化抑制肝细胞脂质沉积.

Objective:To investigate the role and mechanism of ATP6V1B2 in the inhibiton of lipid deposition by promotinglysosomal acidification in lipotoxin-exposed hepatocytes.Methods:Hepatic steatosis model mice were constructed by feeding male C57BL/6 mice with a high-fat diet for 14 weeks.Lipotoxic injury was induced in hepatocyte lines L02 and HepG2 using a mixture of oleic acid and palmitic acid.The expression of ATP6V1B2 gene in L02 cells was knocked down or overexpressed by siRNA and plasmid transfection.The mRNA and protein expressions of ATP6V1B2 were detected by qRT-PCR and Western blotting,respectively.Hepatocyte lipid deposition was detected by oil red O staining and Nile red staining.Lysosomal activity was detected by lyso-tracker in lipotoxic hepatocytes.Lysosomal membrane integrity was detected by acridine orange staining.The JASPAR database was used to predict transcription factors regulating ATP6V1B2,and the regulatory effect of transcription factors on ATP6V1B2 expression was verified.Results:Compared with the normal control group,ATP6V1B2 expression was decreased in hepatic tissues of high-fat diet mice and lipotoxic hepatocytes(P<0.05).ATP6V1B2 knockdown exacerbated hepatocyte lipid deposition,inhibited hepatocyte lysosomal acidification,and increased hepatocyte lysosomal membrane permeability.Overexpression of ATP6V1B2 alleviated cellular lipid deposition.Transcription factor SP1 could transcriptionally regulate ATP6V1B2 expression.Compared with the control group,silencing SP1 upregulates the mRNA and protein expression of ATP6V1B2 in L02 cells(P<0.01).Conclusion:ATP6V1B2 may inhibit hepatocyte lipid deposition by promoting hepatocyte lysosomal acidification.

徐瑞姿;李康荣;张琳;严永敏

江苏大学医学院,江苏镇江 212013江苏大学医学院,江苏镇江 212013江苏大学医学院,江苏镇江 212013江苏大学附属武进医院检验医学科,江苏常州 213017

医药卫生

代谢功能障碍相关脂肪性肝病脂质沉积溶酶体液泡ATP酶ATP6V1B2

metabolic dysfunction-associated steatotic liver disease(MASLD)lipid depositionlysosomesV-ATPaseATP6V1B2

《江苏大学学报(医学版)》 2026 (1)

1-8,8

国家自然科学基金资助项目(82272421)

10.13312/j.issn.1671-7783.y250061

评论